Reply to: "A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance:

Hyun Yang1, Si Hyun Bae1, Jeong Won Jang1

  • 1Division of Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea; The Catholic University Liver Research Center, Seoul, Republic of Korea.

Journal of Hepatology
|September 4, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos